Luis Mas

8PUBLICATIONS
126CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Solid tumoursPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 23, 2026
Breast Cancer-Protective Genetic Variant Common in Women of Indigenous American Genetic Ancestry Is a cis-eQTL for RMND1, ARMT1, and CCDC170 in HER2-Enriched Tumor Subtypes.

|Jan 12, 2026
Giant Primary Hepatic Endodermal Sinus Tumor: Multidisciplinary Management and Long-Term Survival.

Katia Roque, Rossana Ruiz, Renier Cruz

|Oct 30, 2025
A Prognostic Signature for Lung Adenocarcinoma in Patients Who Have Never Smoked.

Wei Zhao, Tongwu Zhang, Xing Hua

|Nov 12, 2022
Real-world outcomes of anti-EGFR therapy in advanced non-small cell lung cancer EGFR mutated in Peru.

Marco Galvez-Nino, Rossana Ruiz, Katia Roque

|Nov 11, 2022
The impact of telemedicine on cancer care: real-world experience from a Peruvian institute during the COVID-19 pandemic.

Katia Roque, Rossana Ruiz, Iris Otoya-Fernandez

|Mar 17, 2021
Characteristics and outcomes of thymomas in Latin America: Results from over 10 years of experience (CLICaP-LATimus).

Claudio Martín, Diego Enrico, Luis Mas

Pageof 2

Frequent Collaborators

5 joint publications

Marco Galvez-Nino

4 joint publications

Rossana Ruiz

3 joint publications

Carlos Castaneda

3 joint publications

Tatiana Vidaurre